https://onecancerplace.org/newsroom/over-41000-raised-for-the-cancer-copilot2020-11-15T17:38:44+00:00https://onecancerplace.org/newsroom/financial-advocacy-program-for-gynecologic-cancer-patients2021-09-08T17:50:12+00:00https://onecancerplace.org/newsroom/bending-without-breaking-cancer-covid-19-navigating-now2020-11-15T17:30:17+00:00https://onecancerplace.org/newsroom/top-cancer-tips-from-cancer-survivors2020-11-17T21:04:30+00:00https://onecancerplace.org/newsroom/a-liver-cancer-survivor-shares-her-story2021-09-08T17:49:31+00:00https://onecancerplace.org/newsroom/a-prostate-cancer-survivors-advice-around-cancer-fear2020-11-06T01:08:18+00:00https://onecancerplace.org/newsroom/surviveit-amazon-bookstore-cancer-book-recommendations2021-02-03T15:40:47+00:00https://onecancerplace.org/newsroom/new-genetic-signatures-could-advance-leukemia-precision-medicine2021-09-08T17:51:01+00:00https://onecancerplace.org/newsroom/addressing-5-key-challenges-in-the-cancer-continuum2020-11-15T17:42:21+00:00https://onecancerplace.org/newsroom/head-neck-study-finds-combined-therapy-improves-cancer-patient-results2020-11-06T01:19:56+00:00https://onecancerplace.org/newsroom/cancer-survivor-qa-where-do-you-find-hope-inspiration-strength2021-06-15T18:12:25+00:00https://onecancerplace.org/newsroom/fda-approves-atezolizumab-for-braf-v600-unresectable-or-metastatic-melanoma2021-09-08T17:51:20+00:00https://onecancerplace.org/newsroom/navigating-second-opinions-you-have-the-most-at-stake-navigating-now2020-11-15T18:44:51+00:00https://onecancerplace.org/newsroom/how-crispr-is-changing-cancer-research-and-treatment2020-11-06T01:35:01+00:00https://onecancerplace.org/newsroom/news-release-surviveit-launches-indiegogo-campaign-to-help-patients-navigate-cancer-journey2020-11-27T19:43:07+00:00https://onecancerplace.org/newsroom/surviveits-cancer-copilot-back-our-crowdfunding-campaign-today2020-11-15T17:45:53+00:00https://onecancerplace.org/newsroom/cancer-survivor-qa-the-best-way-to-support-someone-who-has-been-diagnosed-with-cancer2020-11-06T01:40:41+00:00https://onecancerplace.org/newsroom/sarcoma-survivor-story-desmoplastic-small-round-cell-tumor2021-09-08T17:52:02+00:00https://onecancerplace.org/newsroom/cancer-immunotherapy-tied-to-severe-covid-19-outcomes2021-02-01T20:45:14+00:00https://onecancerplace.org/newsroom/fda-approves-avelumab-for-urothelial-carcinoma-maintenance-treatment2020-11-06T01:45:40+00:00https://onecancerplace.org/newsroom/fda-approves-combination-of-pertuzumab-trastuzumab-and-hyaluronidase-zzxf-for-her2-positive-breast2020-11-06T01:48:00+00:00https://onecancerplace.org/newsroom/a-cancer-patients-guide-to-getting-a-remote-second-opinion2020-11-06T01:51:14+00:00https://onecancerplace.org/newsroom/navigating-the-elusive-peace-of-mind-in-cancer-navigating-now2020-11-18T16:40:35+00:00https://onecancerplace.org/newsroom/fda-approves-selinexor-for-relapsed-refractory-diffuse-large-b-cell-lymphoma2020-11-06T01:53:55+00:00https://onecancerplace.org/newsroom/fda-granted-accelerated-approval-to-tazemetostat-for-follicular-lymphoma2020-11-06T01:57:50+00:00https://onecancerplace.org/newsroom/immunotherapy-cancer-patient-story-keeping-a-positive-outlook-when-melanoma-returned2020-11-06T02:00:31+00:00https://onecancerplace.org/newsroom/fda-approves-pembrolizumab-for-adults-and-children-with-tmb-h-solid-tumors2020-11-07T00:11:13+00:00https://onecancerplace.org/newsroom/fda-approves-gemtuzumab-ozogamicin-for-cd33-positive-aml-in-pediatric-patients2020-11-07T00:12:31+00:00https://onecancerplace.org/newsroom/fda-grants-accelerated-approval-to-lurbinectedin-for-metastatic-small-cell-lung-cancer2020-11-07T00:13:47+00:00https://onecancerplace.org/newsroom/cancer-survivor-qa-whats-the-first-thing-to-do-after-a-cancer-diagnosis2021-06-15T18:12:57+00:00https://onecancerplace.org/newsroom/a-cancer-patients-experience-with-immunotherapy2021-09-08T17:53:30+00:00https://onecancerplace.org/newsroom/fda-approves-selumetinib-for-neurofibromatosis-type-1-with-symptomatic-inoperable-plexiform-neurofi2020-11-07T00:17:55+00:00https://onecancerplace.org/newsroom/fda-approves-tucatinib-for-patients-with-her2-positive-metastatic-breast-cancer2020-11-07T00:18:59+00:00https://onecancerplace.org/newsroom/fda-grants-accelerated-approval-to-sacituzumab-govitecan-hziy-for-metastatic-triple-negative-breast2020-11-07T00:20:11+00:00https://onecancerplace.org/newsroom/fda-approves-new-dosing-regimen-for-pembrolizumab2020-11-07T00:21:17+00:00https://onecancerplace.org/newsroom/fda-approves-niraparib-for-first-line-maintenance-of-advanced-ovarian-cancer2020-11-07T00:22:17+00:00https://onecancerplace.org/newsroom/fda-approves-daratumumab-and-hyaluronidase-fihj-for-multiple-myeloma2020-11-07T00:23:17+00:00https://onecancerplace.org/newsroom/fda-approves-tucatinib-for-patients-with-her2-positive-metastatic-breast-cancer-22020-11-07T00:26:26+00:00https://onecancerplace.org/newsroom/fda-grants-accelerated-approval-to-sacituzumab-govitecan-hziy-for-metastatic-triple-negative-breast-22020-11-07T00:27:18+00:00https://onecancerplace.org/newsroom/fda-approves-new-dosing-regimen-for-pembrolizumab-22020-11-07T00:28:21+00:00https://onecancerplace.org/newsroom/836-22020-11-07T00:29:39+00:00https://onecancerplace.org/newsroom/fda-approves-daratumumab-and-hyaluronidase-fihj-for-multiple-myeloma-22020-11-07T00:30:39+00:00https://onecancerplace.org/newsroom/fda-grants-accelerated-approval-to-capmatinib-for-metastatic-non-small-cell-lung-cancer2020-11-07T00:31:38+00:00https://onecancerplace.org/newsroom/fda-approves-nivolumab-plus-ipilimumab-for-first-line-mnsclc-pd-l1-tumor-expression-%e2%89%a512020-11-07T00:32:32+00:00https://onecancerplace.org/newsroom/fda-grants-accelerated-approval-to-rucaparib-for-brca-mutated-metastatic-castration-resistant-prosta2020-11-07T00:33:27+00:00https://onecancerplace.org/newsroom/fda-approves-ripretinib-for-advanced-gastrointestinal-stromal-tumor2020-11-07T00:34:22+00:00https://onecancerplace.org/newsroom/fda-approves-atezolizumab-for-first-line-treatment-of-metastatic-nsclc-with-high-pd-l1-expression2020-11-07T00:35:16+00:00https://onecancerplace.org/newsroom/fda-approves-olaparib-for-hrr-gene-mutated-metastatic-castration-resistant-prostate-cancer2020-11-07T00:36:17+00:00https://onecancerplace.org/newsroom/fda-approves-brigatinib-for-alk-positive-metastatic-nsclc2020-11-07T00:37:13+00:00https://onecancerplace.org/newsroom/fda-approves-nivolumab-plus-ipilimumab-and-chemotherapy-for-first-line-treatment-of-metastatic-nsclc2020-11-07T00:38:07+00:00https://onecancerplace.org/newsroom/fda-approves-ramucirumab-plus-erlotinib-for-first-line-metastatic-nsclc2020-11-07T00:39:08+00:00https://onecancerplace.org/newsroom/navigating-conflicted-validation-navigating-now2020-11-07T00:40:57+00:00https://onecancerplace.org/newsroom/6-warning-signs-of-melanoma2021-09-08T17:53:47+00:00https://onecancerplace.org/newsroom/advocating-for-yourself-advice-from-a-bladder-cancer-survivor2021-09-08T17:54:11+00:00https://onecancerplace.org/newsroom/the-importance-of-screening-womens-health-month2021-09-08T17:54:53+00:00https://onecancerplace.org/newsroom/big-news-for-braf-mutant-melanoma-patients2021-09-08T17:55:04+00:00https://onecancerplace.org/newsroom/coronavirus-from-the-perspective-of-a-cancer-clinic-nurse2020-11-07T00:49:18+00:00https://onecancerplace.org/newsroom/breast-cancer-news-some-patients-ned-after-new-combo2021-09-08T17:55:34+00:00https://onecancerplace.org/newsroom/navigating-the-future-with-hope-and-resilience-navigating-now2020-11-07T00:52:01+00:00https://onecancerplace.org/newsroom/a-testicular-cancer-survivor-shares-his-ups-and-downs2021-09-08T17:55:57+00:00https://onecancerplace.org/newsroom/fda-approval-updates2020-11-07T00:55:39+00:00https://onecancerplace.org/newsroom/tips-for-life-as-an-esophageal-cancer-survivor2021-09-08T17:56:11+00:00https://onecancerplace.org/newsroom/new-fda-approval-for-locally-advanced-or-metastatic-cholangiocarcinoma2020-11-07T00:58:38+00:00https://onecancerplace.org/newsroom/a-head-neck-cancer-survivors-message-for-others2020-11-07T01:00:09+00:00https://onecancerplace.org/newsroom/techniques-for-targeted-molecular-therapy-in-head-and-neck-squamous-cell-carcinoma2021-09-08T17:56:31+00:00https://onecancerplace.org/newsroom/what-are-the-signs-of-testicular-cancer-5-signs-to-be-aware-of2021-09-08T17:57:03+00:00https://onecancerplace.org/newsroom/bristol-myers-squibb-expands-patient-support-programs-to-help-newly-uninsured-patients-in-the-u-s2020-11-07T01:04:44+00:00https://onecancerplace.org/newsroom/what-eye-cancer-looks-like-questions-to-ask-your-doctor2021-09-08T17:57:37+00:00https://onecancerplace.org/newsroom/fda-approves-isatuximab-irfc-for-multiple-myeloma2020-11-07T01:07:32+00:00https://onecancerplace.org/newsroom/fda-approves-durvalumab-for-extensive-stage-small-cell-lung-cancer2020-11-07T01:08:50+00:00https://onecancerplace.org/newsroom/a-doctor-gave-scott-10-months-to-live-over-8-years-ago-kidney-cancer-survivor-story2021-09-08T17:58:01+00:00https://onecancerplace.org/newsroom/life-after-multiple-myeloma-a-survivor-story2021-09-08T17:58:21+00:00https://onecancerplace.org/newsroom/what-are-the-symptoms-of-anal-cancer2021-09-08T17:58:58+00:00https://onecancerplace.org/newsroom/are-the-treatments-for-kidney-cancer-advancing2021-09-08T17:59:25+00:00https://onecancerplace.org/newsroom/covid-19-coronavirus-and-cancer2021-02-03T15:29:05+00:00https://onecancerplace.org/newsroom/who-we-are-what-we-do-why-we-do-it-surviveit2021-09-08T18:00:17+00:00https://onecancerplace.org/newsroom/fda-approves-neratinib-for-metastatic-her2-positive-breast-cancer2020-11-07T01:19:06+00:00https://onecancerplace.org/newsroom/a-childhood-cancer-survivor-shares-her-story2021-09-08T18:02:58+00:00https://onecancerplace.org/newsroom/prioritize-cancer-prevention-with-these-12-actions2020-11-07T02:37:14+00:00https://onecancerplace.org/newsroom/all-can-reports-on-cancer-care-inefficiencies-from-the-patients-perspective2021-09-08T18:03:18+00:00https://onecancerplace.org/newsroom/researchers-find-newly-discovered-part-of-immune-system-may-treat-all-cancers2021-09-08T18:04:00+00:00https://onecancerplace.org/newsroom/research-findings-on-the-connection-between-obesity-and-cancer2020-11-07T02:54:25+00:00https://onecancerplace.org/newsroom/when-to-get-screened-cervical-cancer-screenings-by-age2021-09-08T18:04:30+00:00https://onecancerplace.org/newsroom/cervical-cancer-screening-pap-hpv-test-guidelines2021-09-08T18:04:45+00:00https://onecancerplace.org/newsroom/signs-symptoms-of-cervical-cancer-every-woman-should-know2021-09-08T18:05:01+00:00https://onecancerplace.org/newsroom/a-look-back-at-2019-fda-approvals-by-cancer-type2020-11-07T03:04:13+00:00https://onecancerplace.org/newsroom/tips-to-help-you-get-through-the-holiday-season2020-11-25T19:25:03+00:00https://onecancerplace.org/newsroom/finding-grace-in-grief-an-oncologists-perspective2020-11-07T03:11:42+00:00https://onecancerplace.org/newsroom/additional-evidence-found-to-connect-ctdnas-potential-role-in-colon-cancer2020-11-07T03:14:21+00:00https://onecancerplace.org/newsroom/6-ways-you-can-support-surviveit-end-of-year-giving2020-11-25T20:07:31+00:00https://onecancerplace.org/newsroom/a-tribute-to-our-founder-matt-ellefson2020-11-07T03:18:11+00:00https://onecancerplace.org/newsroom/pledge-10-this-giving-tuesday-to-change-the-way-people-face-cancer2020-11-07T03:19:37+00:00https://onecancerplace.org/newsroom/pancreatic-cancer-warning-signs-symptoms2021-09-08T18:05:17+00:00https://onecancerplace.org/newsroom/your-holiday-wine-shopping-can-support-surviveit-this-year2020-11-07T03:22:55+00:00https://onecancerplace.org/newsroom/signs-of-medical-burnout-for-physicians-what-it-means-for-your-health-care2020-11-07T03:24:40+00:00https://onecancerplace.org/newsroom/10-tips-for-cancer-caregivers-national-family-caregiver-month2020-11-07T03:26:06+00:00https://onecancerplace.org/newsroom/5-year-study-finds-treatment-to-improve-overall-survival-in-advanced-nsclc2021-09-08T18:05:33+00:00https://onecancerplace.org/newsroom/fearless-friday-cancer-research-what-it-does-for-all-patients2020-11-07T03:30:06+00:00https://onecancerplace.org/newsroom/fda-approves-niraparib-for-hrd-positive-advanced-ovarian-cancer2020-11-07T03:34:42+00:00https://onecancerplace.org/newsroom/1015-22021-09-08T18:06:10+00:00https://onecancerplace.org/newsroom/regular-exercise-can-improve-quality-of-life-for-breast-cancer-patients2021-09-08T18:05:52+00:00https://onecancerplace.org/newsroom/surviveit-online-store-is-now-open2020-11-08T00:08:55+00:00https://onecancerplace.org/newsroom/5-health-quality-tips-anyone-can-use2021-09-08T18:06:25+00:00https://onecancerplace.org/newsroom/how-to-perform-a-male-breast-exam-self-check-male-breast-cancer-awareness2021-09-08T18:06:43+00:00https://onecancerplace.org/newsroom/10-year-retrospective-study-shows-improvements-in-liver-cancer-survival-rates2021-09-08T18:07:05+00:00https://onecancerplace.org/newsroom/link-to-rare-cancer-causes-breast-implants-to-be-recalled2021-09-08T18:07:33+00:00https://onecancerplace.org/newsroom/combination-therapy-can-improve-outcome-for-advanced-liver-cancer2020-11-08T00:15:45+00:00https://onecancerplace.org/newsroom/real-thoughts-that-cross-a-breast-cancer-patients-mind2021-09-08T18:08:02+00:00https://onecancerplace.org/newsroom/denver-fundraiser2020-11-08T00:20:50+00:00https://onecancerplace.org/newsroom/a-connection-between-nutrients-and-follicular-lymphoma-discovered-in-new-study2021-09-08T18:08:20+00:00https://onecancerplace.org/newsroom/md-says-young-exposure-to-radiation-increases-risk-for-developing-thyroid-cancer2021-09-08T18:08:41+00:00https://onecancerplace.org/newsroom/heres-what-you-need-to-know-about-gynecologic-cancers2020-11-08T00:27:12+00:00https://onecancerplace.org/newsroom/childhood-cancer-awareness-u-s-trends-in-childrens-cancer2021-09-08T18:09:52+00:00https://onecancerplace.org/newsroom/3-studies-show-no-association-between-tumor-mutational-burden-and-key-outcomes-in-nsclc2020-11-08T00:30:22+00:00https://onecancerplace.org/newsroom/fda-approves-combo-keytruda-lenvima-for-some-endometrial-carcinoma-patients2020-11-08T00:32:08+00:00https://onecancerplace.org/newsroom/on-september-17-2019-the-food-and-drug-administration-granted-accelerated-approval-to-the-combination-of-pembrolizumab-keytruda-merck-plus-lenvatinib-lenvima-eisai-for-the-treatment-of-patient2021-09-08T18:10:14+00:00https://onecancerplace.org/newsroom/how-a-leukemia-diagnosis-led-to-donor-awareness-a-clothing-line2021-09-08T18:10:33+00:00https://onecancerplace.org/newsroom/risk-of-developing-ovarian-cancer-symptoms-new-guidelines-for-testing2021-09-08T18:11:05+00:00https://onecancerplace.org/newsroom/tips-for-coping-with-a-cancer-diagnosis2021-09-08T18:11:29+00:00https://onecancerplace.org/newsroom/a-skin-cancer-survivor-shares-3-ways-to-protect-your-skin2020-11-08T00:44:37+00:00https://onecancerplace.org/newsroom/navigating-shared-decision-making-in-the-cancer-setting-navigating-now2020-11-17T14:46:18+00:00https://onecancerplace.org/newsroom/fda-approves-entrectinib-for-ntrk-solid-tumors-and-ros-1-nsclc2020-11-12T00:28:19+00:00https://onecancerplace.org/newsroom/fda-approves-pembrolizumab-for-pd-l1-esophageal-squamous-cell-carcinoma2020-11-12T00:29:52+00:00https://onecancerplace.org/newsroom/fda-approves-bayers-nubeqa-darolutamide-for-non-metastatic-castration-resistant-prostate-cancer2020-11-12T00:31:13+00:00https://onecancerplace.org/newsroom/surviveit-giving-week-20192020-11-12T00:35:19+00:00https://onecancerplace.org/newsroom/surviveit-how-can-you-encourage-others-to-support2020-11-12T00:41:42+00:00https://onecancerplace.org/newsroom/surviveit-what-role-will-you-play2020-11-12T00:44:37+00:00https://onecancerplace.org/newsroom/what-was-that-again2020-11-12T00:46:28+00:00https://onecancerplace.org/newsroom/fda-approves-daratumumab-for-multiple-myeloma-ineligible-for-autologous-stem-cell-transplant2020-11-12T00:47:52+00:00https://onecancerplace.org/newsroom/fda-approves-pembrolizumab-for-metastatic-small-cell-lung-cancer2020-11-12T00:49:09+00:00https://onecancerplace.org/newsroom/fda-approves-pembrolizumab-for-first-line-treatment-of-head-and-neck-squamous-cell-carcinoma2020-11-12T00:50:25+00:00https://onecancerplace.org/newsroom/fearless-friday-cancer-research-what-it-does-for-all-patients-22020-11-12T00:51:59+00:00https://onecancerplace.org/newsroom/fda-expands-pembrolizumab-indication-for-first-line-treatment-of-nsclc2020-11-12T00:54:51+00:00https://onecancerplace.org/newsroom/fda-grants-accelerated-approval-to-erdafitinib-for-metastatic-urothelial-carcinoma2020-11-12T00:58:01+00:00https://onecancerplace.org/newsroom/fda-approves-pembrolizumab-plus-axitinib-for-advanced-renal-cell-carcinoma2020-11-12T00:59:27+00:00https://onecancerplace.org/newsroom/fda-approves-lonsurf-for-recurrent-metastatic-gastric-and-gastroesophageal-junction-adenocarcinoma2020-11-12T01:02:10+00:00https://onecancerplace.org/newsroom/relax-comorbidity-criteria-in-cancer-trials2020-11-12T01:03:59+00:00https://onecancerplace.org/newsroom/fda-approves-herzuma-as-a-biosimilar-to-herceptin-for-breast-cancer2020-11-12T01:05:14+00:00https://onecancerplace.org/newsroom/fda-approves-olaparib-for-first-line-maintenance-of-brca-mutated-advanced-ovarian-cancer2020-11-12T01:06:33+00:00https://onecancerplace.org/newsroom/fda-approves-longer-acting-calaspargase-pegol-mknl-for-all2020-11-12T01:08:17+00:00https://onecancerplace.org/newsroom/fda-approves-cabozantinib-for-hepatocellular-carcinoma2020-11-12T01:09:21+00:00https://onecancerplace.org/newsroom/surviveit-mourns-death-of-founder-and-former-ceo-matt-j-ellefson2020-11-12T01:11:17+00:00https://onecancerplace.org/newsroom/rest-in-love-our-fearless-leader2020-11-12T01:12:43+00:00https://onecancerplace.org/newsroom/fda-approves-glasdegib-for-aml-in-adults-age-75-or-older-or-who-have-comorbidities2020-11-12T01:13:56+00:00https://onecancerplace.org/newsroom/fda-approves-brentuximab-vedotin-for-previously-untreated-salcl-and-cd30-expressing-ptcl2020-11-12T01:15:00+00:00https://onecancerplace.org/newsroom/fda-grants-accelerated-approval-to-pembrolizumab-for-hepatocellular-carcinoma2020-11-12T01:15:54+00:00https://onecancerplace.org/newsroom/fda-approves-truxima-as-biosimilar-to-rituxan-for-non-hodgkins-lymphoma2020-11-12T01:17:01+00:00https://onecancerplace.org/newsroom/fda-approves-gilteritinib-for-relapsed-or-refractory-aml-with-a-flt3-mutation2020-11-12T01:21:32+00:00https://onecancerplace.org/newsroom/fda-approves-vitrakvi-based-on-shared-mutation-rather-than-a-specific-type-of-tumor2020-11-12T01:22:43+00:00https://onecancerplace.org/newsroom/groundbreaking-results-with-pembrolizumab-plus-surgery-in-bladder-cancer2020-11-12T01:24:05+00:00https://onecancerplace.org/newsroom/fda-announces-first-approval-for-newly-diagnosed-ptcl2020-11-12T01:25:04+00:00https://onecancerplace.org/newsroom/australian-kazia-therapeutics-presents-trial-in-progress-data-for-glioblastoma-study2020-11-12T01:36:12+00:00https://onecancerplace.org/newsroom/shared-decision-making-real-or-just-a-feel-good-buzzword2020-11-12T01:38:20+00:00https://onecancerplace.org/newsroom/fda-approves-lorlatinib-for-alk-nsclc2020-11-12T01:39:57+00:00https://onecancerplace.org/newsroom/surviveit-names-executive-director-joy-brewster-rusthoven-to-lead-patient-advocacy-nonprofit2020-11-12T01:41:16+00:00https://onecancerplace.org/newsroom/fda-approves-talazoparib-for-gbrcam-her2-negative-locally-advanced-or-metastatic-breast-cancer2020-11-12T01:42:26+00:00https://onecancerplace.org/newsroom/fda-approves-copiktra-for-leukemia-lymphoma-subtypes2020-11-12T01:43:54+00:00https://onecancerplace.org/newsroom/rucaparib-granted-breakthrough-designation-by-fda-for-mcrpc2020-11-12T01:45:17+00:00https://onecancerplace.org/newsroom/fda-approves-first-treatment-for-advanced-form-of-the-second-most-common-skin-cancer2020-11-12T01:46:54+00:00https://onecancerplace.org/newsroom/study-shows-value-of-breast-cancer-patients-seeking-second-opinions2020-11-12T01:48:22+00:00https://onecancerplace.org/newsroom/world-lung-2018-alunbrig-squares-up-to-xalkori-but-the-field-is-getting-crowded2020-11-12T01:49:34+00:00https://onecancerplace.org/newsroom/first-line-brigatinib-improves-pfs-for-alk-positive-non-small-cell-lung-cancer2020-11-12T01:50:34+00:00https://onecancerplace.org/newsroom/fda-approves-dacomitinib-for-metastatic-non-small-cell-lung-cancer2020-11-12T01:51:54+00:00https://onecancerplace.org/newsroom/cancer-doesnt-frighten-me2020-11-12T01:53:34+00:00https://onecancerplace.org/newsroom/takeda-receives-positive-chmp-opinion-recommending-brigatinib-for-treatment-of-alk-nsclc2020-11-12T01:55:33+00:00https://onecancerplace.org/newsroom/fda-approves-moxetumomab-pasudotox-tdfk-for-hairy-cell-leukemia2020-11-12T01:56:40+00:00https://onecancerplace.org/newsroom/mogamulizumab-approved-for-two-rare-types-of-cutaneous-t-cell-lymphoma2020-11-12T01:57:44+00:00https://onecancerplace.org/newsroom/dont-blame-rural-cancer-patients-for-their-poorer-health-outcomes2020-11-12T01:59:24+00:00https://onecancerplace.org/newsroom/tailored-drug-cocktails-offer-hope-to-kids-with-aggressive-brain-tumors2020-11-12T02:00:38+00:00https://onecancerplace.org/newsroom/imbruvica-rituximab-becomes-first-non-chemo-combination-for-waldenstroms-macroglobulinemia2020-11-12T02:01:47+00:00https://onecancerplace.org/newsroom/fearless-friday-radiation-part-ii-how-radiation-oncologists-think-about-treatment-options2020-11-12T02:03:39+00:00https://onecancerplace.org/newsroom/fda-grants-approval-for-1st-line-treatment-of-metastatic-nonsquamous-nsclc2020-11-12T02:05:43+00:00https://onecancerplace.org/newsroom/fda-grants-accelerated-approval-for-3rd-line-treatment-of-metastatic-small-cell-lung-cancer2020-11-12T02:06:58+00:00https://onecancerplace.org/newsroom/media-release-surviveit-launches-its-cancer-navigation-tool-lung-edition2020-11-18T22:44:32+00:00https://onecancerplace.org/newsroom/the-pandemics-ripple-effect-on-cancer2020-11-25T18:54:06+00:00https://onecancerplace.org/newsroom/cancer-patient-gift-guide2021-09-29T14:09:35+00:00https://onecancerplace.org/newsroom/2020-caregiver-gift-guide-surviveit2021-09-29T14:10:57+00:00https://onecancerplace.org/newsroom/2020-fda-approvals-by-cancer-type2020-12-30T14:36:31+00:00https://onecancerplace.org/newsroom/10-ways-to-help-a-friend-with-cancer2020-12-11T18:50:40+00:00https://onecancerplace.org/newsroom/cancer-navigation-tool-faq2021-08-25T17:48:53+00:00https://onecancerplace.org/newsroom/how-to-get-started-with-surviveits-cancer-navigation-tool2021-01-15T20:35:21+00:00https://onecancerplace.org/newsroom/what-cancer-patients-should-know-about-the-covid-19-vaccine2021-02-05T16:42:49+00:00https://onecancerplace.org/newsroom/empowering-women-to-advocate-for-themselves2021-03-08T15:04:07+00:00https://onecancerplace.org/newsroom/how-to-get-a-thorough-cancer-diagnosis-step-1-testit2021-02-10T17:10:09+00:00https://onecancerplace.org/newsroom/covid-19-vaccines-cancer-priorities2021-02-11T20:09:08+00:00https://onecancerplace.org/newsroom/how-to-get-a-qualified-second-opinion-review-of-molecular-profiling-step-2-verifyit2021-02-10T17:10:12+00:00https://onecancerplace.org/newsroom/how-to-define-your-personal-goals-during-your-cancer-treatment-step-3-matchit2021-02-10T17:10:15+00:00https://onecancerplace.org/newsroom/how-to-manage-side-effects-of-cancer-treatments-step-4-supportit2021-02-10T17:10:16+00:00https://onecancerplace.org/newsroom/how-to-manage-cancer-outside-of-treatment-cancer-survivor-vetted-resource-library-step-5-liveit2021-02-10T17:10:18+00:00https://onecancerplace.org/newsroom/how-to-thank-your-doctor-or-nurse-thank-you-card-downloads2021-03-24T18:05:08+00:00https://onecancerplace.org/newsroom/new-study-from-foundation-medicine-and-collaborators-further-demonstrates-the-clinical-utility-of-blood-based-comprehensive-genomic-profiling-in-patients-with-advanced-prostate-cancer2021-02-24T18:33:34+00:00https://onecancerplace.org/newsroom/fda-approves-cemiplimab-rwlc-for-non-small-cell-lung-cancer-with-high-pd-l1-expression2021-09-08T17:49:00+00:00https://onecancerplace.org/newsroom/tnbc-foundation-explains-3-myths-about-triple-negative-breast-cancer2021-09-08T17:48:46+00:00https://onecancerplace.org/newsroom/advice-for-cancer-caregivers-in-a-supportive-role2021-04-30T18:48:03+00:00https://onecancerplace.org/newsroom/advice-for-cancer-caregivers-in-a-decision-making-role2021-04-21T15:08:39+00:00https://onecancerplace.org/newsroom/tips-for-cancer-caregivers2021-03-31T14:05:44+00:00https://onecancerplace.org/newsroom/7-pets-that-have-helped-cancer-patients-finding-comfort-in-our-pets2021-04-09T14:58:03+00:00https://onecancerplace.org/newsroom/books-about-cancer-for-children2021-04-21T14:12:53+00:00https://onecancerplace.org/newsroom/the-tools-that-allow-me-to-address-my-cancer-with-less-fear-and-more-hope2021-09-08T17:47:15+00:00https://onecancerplace.org/newsroom/a-5-step-approach-to-personalized-planning-after-a-cancer-diagnosis2021-08-18T16:33:42+00:00https://onecancerplace.org/newsroom/fda-approves-nivolumab-in-combination-with-chemotherapy-for-metastatic-gastric-cancer-and-esophageal-adenocarcinoma2021-09-08T17:48:17+00:00https://onecancerplace.org/newsroom/fda-grants-accelerated-approval-to-dostarlimab-gxly-for-dmmr-endometrial-cancer2021-09-08T17:47:53+00:00https://onecancerplace.org/newsroom/fda-grants-accelerated-approval-to-loncastuximab-tesirine-lpyl-for-large-b-cell-lymphoma2021-09-08T17:47:37+00:00https://onecancerplace.org/newsroom/bladder-cancer-patient-stories-plus-signs-symptoms-to-be-aware-of2021-09-08T17:46:54+00:00https://onecancerplace.org/newsroom/surviveits-2021-giving-week-is-here2021-05-16T12:53:39+00:00https://onecancerplace.org/newsroom/2021-giving-week-results-are-in2021-06-02T14:54:37+00:00https://onecancerplace.org/newsroom/an-unexpected-life-after-cancer-tools-to-help-manage-it2021-09-08T17:46:43+00:00https://onecancerplace.org/newsroom/cancer-survivors-share-their-top-advice2021-06-15T18:15:54+00:00https://onecancerplace.org/newsroom/have-you-added-this-anti-cancer-superfood-to-your-diet2021-06-21T17:52:09+00:00https://onecancerplace.org/newsroom/the-top-questions-that-run-through-your-mind-after-a-cancer-diagnosis2021-07-14T18:22:06+00:00https://onecancerplace.org/newsroom/sarcoma-patient-stories-plus-signs-symptoms2021-09-08T17:46:17+00:00https://onecancerplace.org/newsroom/5-changes-to-make-to-your-kitchen-during-cancer-treatment2021-09-28T20:17:26+00:00https://onecancerplace.org/newsroom/colon-cancer-patient-stories-plus-prevention-signs-symptoms2021-09-20T15:36:33+00:00https://onecancerplace.org/newsroom/5-sun-safety-habits-to-get-into-this-month2021-08-10T14:50:27+00:00https://onecancerplace.org/newsroom/7-changes-to-make-to-your-living-room-during-cancer-treatment2021-09-28T20:17:42+00:00https://onecancerplace.org/newsroom/8-changes-to-make-to-your-bedroom-during-cancer-treatment2021-09-28T20:17:35+00:00https://onecancerplace.org/newsroom/the-cancer-liberation-project-podcast2021-09-08T17:42:39+00:00https://onecancerplace.org/newsroom/breast-cancer-patient-stories-plus-stats-on-genetic-stats2021-10-06T16:53:19+00:00https://onecancerplace.org/newsroom/5-changes-to-make-to-your-outdoor-space-during-cancer-treatment2021-09-28T20:16:31+00:00https://onecancerplace.org/newsroom/fda-grants-accelerated-approval-to-dostarlimab-gxly-for-dmmr-advanced-solid-tumors2021-08-27T16:05:37+00:00https://onecancerplace.org/newsroom/fda-approves-nivolumab-for-adjuvant-treatment-of-urothelial-carcinoma2021-08-27T16:12:13+00:00https://onecancerplace.org/newsroom/interview-with-the-executive-director-of-harmony-hill2021-09-16T13:57:16+00:00https://onecancerplace.org/newsroom/one-of-a-kind-list-of-lung-cancer-experts-the-top-lung-cancer-doctors2021-09-22T13:37:06+00:00https://onecancerplace.org/newsroom/surviveit-launches-its-cancer-navigation-tool-colon-edition2021-09-14T13:04:24+00:00https://onecancerplace.org/newsroom/3-things-i-heard-as-a-caregiver-that-werent-exactly-helpful2021-11-22T20:45:51+00:00https://onecancerplace.org/newsroom/3-things-i-heard-as-a-caregiver-that-were-helpful2021-11-22T20:45:49+00:00https://onecancerplace.org/newsroom/one-of-a-kind-list-of-colon-cancer-experts-the-top-colon-cancer-doctors2021-10-06T16:43:26+00:00https://onecancerplace.org/newsroom/fda-approves-tebentafusp-tebn-for-unresectable-or-metastatic-uveal-melanoma2022-04-26T22:19:24+00:00https://onecancerplace.org/newsroom/fda-approves-ciltacabtagene-autoleucel-for-relapsed-or-refractory-multiple-myeloma2022-04-26T22:20:40+00:00https://onecancerplace.org/newsroom/fda-approves-neoadjuvant-nivolumab-and-platinum-doublet-chemotherapy-for-early-stage-non-small-cell-lung-cancer2022-04-26T22:21:32+00:00https://onecancerplace.org/newsroom/fda-approves-olaparib-for-adjuvant-treatment-of-high-risk-early-breast-cancer2022-04-26T22:22:11+00:00https://onecancerplace.org/newsroom/fda-approves-opdualag-for-unresectable-or-metastatic-melanoma2022-04-26T22:22:55+00:00https://onecancerplace.org/newsroom/fda-approves-pembrolizumab-for-advanced-endometrial-carcinoma2022-04-26T22:23:36+00:00https://onecancerplace.org/newsroom/fda-approves-pluvicto-for-metastatic-castration-resistant-prostate-cancer2022-04-26T22:24:25+00:00https://onecancerplace.org/newsroom/fda-approves-axicabtagene-ciloleucel-for-second-line-treatment-of-large-b-cell-lymphoma2022-04-26T22:25:14+00:00https://onecancerplace.org/newsroom/fda-approves-capmatinib-for-metastatic-non-small-cell-lung-cancer2022-08-31T15:52:11+00:00https://onecancerplace.org/newsroom/breaking-news-surviveit-merges-with-one-cancer-place2022-12-16T00:30:26+00:00